Finally, it must be take into account that NRF2 levels can be regulated in a KEAP1-indipendent way by carcinoid tumor-related oncogenes, so their profile should impact and must be monitored to predict a tumor response to pharmacological treatments [67]. This evidence concerns the gene NFE2L2 and neoplasm.